BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37523713)

  • 21. Activation of prostaglandin EP4 receptor attenuates the induction of cyclooxygenase-2 expression by EP2 receptor activation in human amnion fibroblasts: implications for parturition.
    Lu JW; Wang WS; Zhou Q; Gan XW; Myatt L; Sun K
    FASEB J; 2019 Jul; 33(7):8148-8160. PubMed ID: 30917001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of prostanoid EP agonists on mouse intraocular pressure.
    Saeki T; Ota T; Aihara M; Araie M
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2201-8. PubMed ID: 19117925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelial E-type prostanoid 4 receptors promote barrier function and inhibit neutrophil trafficking.
    Konya V; Üllen A; Kampitsch N; Theiler A; Philipose S; Parzmair GP; Marsche G; Peskar BA; Schuligoi R; Sattler W; Heinemann A
    J Allergy Clin Immunol; 2013 Feb; 131(2):532-40.e1-2. PubMed ID: 22704539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostanoid receptor expression by human airway smooth muscle cells and regulation of the secretion of granulocyte colony-stimulating factor.
    Clarke DL; Belvisi MG; Smith SJ; Hardaker E; Yacoub MH; Meja KK; Newton R; Slater DM; Giembycz MA
    Am J Physiol Lung Cell Mol Physiol; 2005 Feb; 288(2):L238-50. PubMed ID: 15640521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostaglandin E2 prevents hyperosmolar-induced human mast cell activation through prostanoid receptors EP2 and EP4.
    Torres-Atencio I; Ainsua-Enrich E; de Mora F; Picado C; Martín M
    PLoS One; 2014; 9(10):e110870. PubMed ID: 25329458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endogenous prostaglandin E
    Samuchiwal SK; Balestrieri B; Raff H; Boyce JA
    J Biol Chem; 2017 May; 292(20):8195-8206. PubMed ID: 28341741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vasorelaxation induced by prostaglandin E2 in human pulmonary vein: role of the EP4 receptor subtype.
    Foudi N; Kotelevets L; Louedec L; Leséche G; Henin D; Chastre E; Norel X
    Br J Pharmacol; 2008 Aug; 154(8):1631-9. PubMed ID: 18516068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of postsynaptic EP4 and presynaptic EP3 receptors in actions of prostaglandin E2 in rat supraoptic neurones.
    Shibuya I; Setiadji SV; Ibrahim N; Harayama N; Maruyama T; Ueta Y; Yamashita H
    J Neuroendocrinol; 2002 Jan; 14(1):64-72. PubMed ID: 11903814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulation.
    Kay LJ; Yeo WW; Peachell PT
    Br J Pharmacol; 2006 Apr; 147(7):707-13. PubMed ID: 16432506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An EP2 Agonist Facilitates NMDA-Induced Outward Currents and Inhibits Dendritic Beading through Activation of BK Channels in Mouse Cortical Neurons.
    Hayashi Y; Morinaga S; Liu X; Zhang J; Wu Z; Yokoyama T; Nakanishi H
    Mediators Inflamm; 2016; 2016():5079597. PubMed ID: 27298516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antagonism of the prostaglandin E2 EP1 receptor in MDCK cells increases growth through activation of Akt and the epidermal growth factor receptor.
    Taub M; Parker R; Mathivanan P; Ariff MA; Rudra T
    Am J Physiol Renal Physiol; 2014 Sep; 307(5):F539-50. PubMed ID: 25007872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells.
    Timoshenko AV; Xu G; Chakrabarti S; Lala PK; Chakraborty C
    Exp Cell Res; 2003 Oct; 289(2):265-74. PubMed ID: 14499627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostaglandin E2 inhibits migration of colonic lamina propria fibroblasts.
    Rieder F; Georgieva M; Schirbel A; Artinger M; Zügner A; Blank M; Brenmoehl J; Schölmerich J; Rogler G
    Inflamm Bowel Dis; 2010 Sep; 16(9):1505-13. PubMed ID: 20803697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cooperation of two subtypes of PGE2 receptor, Gi coupled EP3 and Gs coupled EP2 or EP4 subtype].
    Hatae N
    Yakugaku Zasshi; 2003 Oct; 123(10):837-43. PubMed ID: 14577329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The vasopressin type 2 receptor and prostaglandin receptors EP2 and EP4 can increase aquaporin-2 plasma membrane targeting through a cAMP-independent pathway.
    Olesen ET; Moeller HB; Assentoft M; MacAulay N; Fenton RA
    Am J Physiol Renal Physiol; 2016 Nov; 311(5):F935-F944. PubMed ID: 27558562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostaglandin E2 enhances interleukin-8 production via EP4 receptor in human pulmonary microvascular endothelial cells.
    Aso H; Ito S; Mori A; Morioka M; Suganuma N; Kondo M; Imaizumi K; Hasegawa Y
    Am J Physiol Lung Cell Mol Physiol; 2012 Jan; 302(2):L266-73. PubMed ID: 22080750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PGE(2) receptor (EP(4)) agonists: potent dilators of human bronchi and future asthma therapy?
    Benyahia C; Gomez I; Kanyinda L; Boukais K; Danel C; Leséche G; Longrois D; Norel X
    Pulm Pharmacol Ther; 2012 Feb; 25(1):115-8. PubMed ID: 22244823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphorylation of glycogen synthase kinase-3 and stimulation of T-cell factor signaling following activation of EP2 and EP4 prostanoid receptors by prostaglandin E2.
    Fujino H; West KA; Regan JW
    J Biol Chem; 2002 Jan; 277(4):2614-9. PubMed ID: 11706038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostaglandin E₂ inhibits human lung fibroblast chemotaxis through disparate actions on different E-prostanoid receptors.
    Li YJ; Wang XQ; Sato T; Kanaji N; Nakanishi M; Kim M; Michalski J; Nelson AJ; Sun JH; Farid M; Basma H; Patil A; Toews ML; Liu X; Rennard SI
    Am J Respir Cell Mol Biol; 2011 Jan; 44(1):99-107. PubMed ID: 20203295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification in human airways smooth muscle cells of the prostanoid receptor and signalling pathway through which PGE2 inhibits the release of GM-CSF.
    Clarke DL; Belvisi MG; Catley MC; Yacoub MH; Newton R; Giembycz MA
    Br J Pharmacol; 2004 Apr; 141(7):1141-50. PubMed ID: 15023863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.